1. Home
  2. LEDS vs INAB Comparison

LEDS vs INAB Comparison

Compare LEDS & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SemiLEDS Corporation

LEDS

SemiLEDS Corporation

N/A

Current Price

$2.33

Market Cap

13.5M

Sector

Technology

ML Signal

N/A

Logo IN8bio Inc.

INAB

IN8bio Inc.

N/A

Current Price

$1.08

Market Cap

11.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LEDS
INAB
Founded
2005
2016
Country
Taiwan
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.5M
11.8M
IPO Year
2010
2020

Fundamental Metrics

Financial Performance
Metric
LEDS
INAB
Price
$2.33
$1.08
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
17.1K
36.4K
Earning Date
04-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
53.12
N/A
EPS
0.02
N/A
Revenue
$43,009,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$105.00
N/A
Revenue Growth
729.81
N/A
52 Week Low
$1.01
$0.88
52 Week High
$3.62
$2.73

Technical Indicators

Market Signals
Indicator
LEDS
INAB
Relative Strength Index (RSI) 58.19 45.67
Support Level $1.76 $0.96
Resistance Level $2.47 $1.22
Average True Range (ATR) 0.13 0.06
MACD 0.02 -0.00
Stochastic Oscillator 97.56 23.81

Price Performance

Historical Comparison
LEDS
INAB

About LEDS SemiLEDS Corporation

SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cellular therapy product candidates and gamma-delta T cell engagers (TCEs) for cancer and autoimmune diseases. Gamma-delta T cells are a specialized population of T cells that possess properties. It has conducted two primary investigator-sponsored Phase 1 clinical trials evaluating its gamma-delta T cell technologies in cancer patients, which have both completed primary enrollment. INB-100 is assessing its DeltEx Allogeneic (Allo) gamma-delta T cell therapy in adult patients with high-risk leukemias undergoing haploidentical stem cell transplantation (HSCT). It operates in a single segment.

Share on Social Networks: